Moderna Wins a Post-COVID Earnings Beat as Analyst Eyes ‘Clinically Meaningful’ Trial Results
Moderna’s ($MRNA) latest earnings were better-than-expected. Jefferies ($JEF) analyst Andrew Tsai explained that while quarterly earnings beat expe...
Merck & Co. Inc. (MRK)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RWC Asset Management Tord Stallvik (Ceo) | 209,086 | $26,867,551 | +2% | 1.02% |
| 2. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 189,357 | $24,332,374 | +460% | 6.55% |
| 3. | Bourgeon Capital John Zaro | 163,890 | $21,060,070 | +1% | 3.1% |
| 4. | Lee Munder Capital Group Lee Munder | 141,678 | $18,205,623 | -1% | 0.98% |
| 5. | Beech Hill Partners Paul Cantor, Joseph Weiss, And Will Wurm | 34,051 | $4,375,609 | +1% | 1.93% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $88.25 | 2,833 | $249,999.98 | 2,933 | 2025-02-06 | Filing | |
| $88.50 | 15,000 | $1,327,500.00 | 16,000 | 2025-02-05 | Filing | |
| $113.68 | 3 | $341.04 | 20,599 | 2023-04-26 | Filing | |
| $105.47 | 136 | $14,343.92 | 20,631 | 2023-03-20 | Filing | |
| $109.20 | 11 | $1,201.20 | 20,495 | 2023-02-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $121.46 | 10,000 | $1,214,562.00 | 60,615 | 2026-02-12 | Filing | |
| $117.52 | 10,235 | $1,202,843.81 | 92,035 | 2026-02-10 | Filing | |
| $118.41 | 10,000 | $1,184,101.00 | 70,615 | 2026-02-09 | Filing | |
| $119.15 | 38,835 | $4,627,275.69 | 68,916 | 2026-02-09 | Filing | |
| $119.15 | 56,792 | $6,766,891.74 | 68,916 | 2026-02-09 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,360,649 | $817,343,408 | 0.7% | |
| 2. | 6,169,107 | $792,730,250 | 0.45% | |
| 3. | 4,309,756 | $553,803,646 | 0.78% | |
| 4. | 2,909,819 | $373,911,742 | 0.47% | |
| 5. | 2,702,992 | $347,334,472 | 0.43% |
News See All
SCHD vs. VYMI: Which Dividend ETF Comes Out on Top?
Dividend ETFs are one of the most popular ways to earn passive income, but choosing the right fund isn’t always easy. Among the leading options are...
Big Pharma Is Buying Growth. Novartis (NVS) Is Betting on Its Pipeline
Biotech M&A has hit a record pace in 2026, with deal value reaching $216 billion so far this year, up from $118 billion over the same stretch last year, according to LSEG data.
Billionaire Cliff Asness’ Top 10 Healthcare Stock Picks
Cliff Asness is a billionaire investor and the co-founder and chief investment officer of AQR Capital Management, a quantitative hedge fund.
10 Reliable Dividend Stocks to Buy for Long-Term Investors
Dividend stocks have long been a favorite among investors focused on building wealth over time.
Is Merck & Co., Inc. (MRK) Strengthening Its Vaccine Portfolio With New Capvaxive Approval?
TheFly reported on June 18 that MRK announced that the U.S.
10 Best Weight Loss Drug Stocks to Buy in 2026
The anti-obesity drug (AOM) market in the United States is rapidly changing structurally.
Kevin O'leary's Stock Portfolio: Top 10 Stock Picks for 2026
Kevin O’Leary’s public investing persona has long leaned toward businesses with cash generation, shareholder returns, and financial discipline rather than high-risk growth stories.
10 Undervalued Counter Cyclical Stocks to Buy Now
Counter-cyclical stocks are getting more attention as investors look for businesses tied to demand that does not disappear just because the economy slows.
Billionaire Ken Fisher’s Top 11 Dividend Stock Picks
In a recent episode of the Market Insights podcast, Fisher Investments Founder, Executive Chairman, and Co-Chief Investment Officer Ken Fisher addressed a new set of listener questions.
Hedge Fund Resource Center